trending Market Intelligence /marketintelligence/en/news-insights/trending/aS-tIKq2pRFrdzrcFWsq7A2 content esgSubNav
In This List

Moody's withdraws BioMed ratings

Blog

Japan M&A By the Numbers: Q1 2022

Blog

Global M&A by the Numbers: Q2 2022

Blog

SEC Climate Disclosure Requirements Heating Up: How to Take Action

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Moody's withdraws BioMed ratings

Moody's withdrew its ratings on , citing its "ownbusiness reasons."

The company's ratings that were withdrawn include its Ba1issuer rating, (P)Ba1 senior unsecured shelf, (P)Ba2 subordinate shelf and(P)Ba2 preferred stock shelf.

Moody's also withdrew BioMed Realty LP's (P)Ba1 seniorunsecured shelf and (P)Ba2 subordinate shelf ratings.

The outlook is negative.

The rating agency in January BioMed after it wastaken out byaffiliates of Blackstone Group LP'sBlackstone Real Estate Partners VIII LP.